Chairman of the Board, Chief Executive Officer and President at OncoMed Pharmaceuticals, Inc.
Paul J. Hastings has served as a member of our board of directors and its chairman since October 2016. Mr. Hastings is the Chairman and CEO of OncoMed Pharmaceuticals (Nasdaq: OMED). Prior to joining OncoMed in 2006, Mr. Hastings was President and Chief Executive Officer of QLT, Inc. Previous to that, Mr. Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals, which was acquired by Celera Corporation in 2001. From 1999 to 2001, Mr. Hastings served as the President of Chiron BioPharmaceuticals, a division of Chiron Corporation. Prior to that, he was President and Chief Executive Officer of LXR Biotechnology. Mr. Hasti ...
Source: Proteon Therapeutics, Inc. on 04/13/2017
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Paul J. Hastings. More specifically, you'll be able to:
Access over 170,000 executive and board member profiles.
Example: Paul J. Hastings
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.